Bisgin, A. Et Al. 2012. Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer. BMC CANCER , vol.12 .

Bisgin, A., Kargi, A., Yalcin, A. D., Aydin, C., Ekinci, D., Savas, B., ... ŞANLIOĞLU, S.(2012). Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer. BMC CANCER , vol.12.

Bisgin, ATIL Et Al. "Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer," BMC CANCER , vol.12, 2012

Bisgin, ATIL Et Al. "Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer." BMC CANCER , vol.12, 2012

Bisgin, A. Et Al. (2012) . "Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer." BMC CANCER , vol.12.

@article{article, author={ATIL BİŞGİN Et Al. }, title={Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer}, journal={BMC CANCER}, year=2012}